Video
ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Timing of response to venetoclax combination treatment in older patients with ac...
Dr Brian Jonas - University of California Davis Comprehensive Cancer Center, Sac...
3 Jun 2020
CheckMate 227 three-year update: Nivolumab plus ipilimumab versus chemo as first...
Prof Suresh Ramalingam - Winship Cancer Institute of Emory University, Atlanta, ...
2 Jun 2020
ASCO 2020: Latest developments in EGFR-mutated non-small cell lung cancer
Prof Benjamin Besse and Dr Alex Spira
2 Jun 2020
Ensuring quality care for breast cancer patients globally
Dr Didier Verhoeven - University of Antwerp, Antwerp, Belgium
1 Jun 2020
Venetoclax with bortezomib and dexamethasone in relapsed/refractory multiple mye...
Dr Shaji Kumar - Mayo Clinic, Rochester, USA
1 Jun 2020
KRd vs VRd for initial therapy of newly diagnosed multiple myeloma
Dr Shaji Kumar - Mayo Clinic, Rochester, USA
1 Jun 2020
Teclistamab for patients with heavily pretreated relapsed or refractory multiple...
Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA
1 Jun 2020
E2108: Systemic therapy plus early local therapy versus systemic therapy alone i...
Dr Seema Ahsan Khan - Northwestern Memorial Hospital, Chicago, USA
31 May 2020
KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy f...
Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York City, USA
31 May 2020
EAU guidelines for treating patients with advanced prostate cancer
Dr Eleni Efstathiou, Prof Álvaro Pinto, Prof Nicolas Mottet and Prof Heather Pay...
31 May 2020
Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and ...
Dr Dimpy Shah - Mays Cancer Center at UT Health San Antonio MD Anderson, San Ant...
31 May 2020
Denosumab in multiple myeloma patients with renal insufficiency
Dr Elizabeth O'Donnell - Massachusetts General Hospital, Boston, USA
30 May 2020
